185 related articles for article (PubMed ID: 31367889)
1. Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols.
Aravindan S; Somasundaram DB; Somasundaram ST; Natarajan M; Herman TS; Aravindan N
Mol Cell Biochem; 2019 Oct; 460(1-2):175-193. PubMed ID: 31367889
[TBL] [Abstract][Full Text] [Related]
2. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer.
Aravindan S; Ramraj SK; Somasundaram ST; Herman TS; Aravindan N
Stem Cell Res Ther; 2015 Sep; 6(1):182. PubMed ID: 26395574
[TBL] [Abstract][Full Text] [Related]
3. Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.
Aravindan S; Ramraj S; Kandasamy K; Thirugnanasambandan SS; Somasundaram DB; Herman TS; Aravindan N
Oncotarget; 2017 Jan; 8(4):5717-5734. PubMed ID: 27974694
[TBL] [Abstract][Full Text] [Related]
4. Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer.
Aravindan S; Ramraj SK; Somasundaram ST; Aravindan N
J Biomed Sci; 2015 Apr; 22(1):28. PubMed ID: 25898131
[TBL] [Abstract][Full Text] [Related]
5. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.
Aravindan S; Delma CR; Thirugnanasambandan SS; Herman TS; Aravindan N
PLoS One; 2013; 8(4):e61977. PubMed ID: 23613993
[TBL] [Abstract][Full Text] [Related]
6. Polyphenol-rich extract of Salvia chinensis exhibits anticancer activity in different cancer cell lines, and induces cell cycle arrest at the G₀/G₁-phase, apoptosis and loss of mitochondrial membrane potential in pancreatic cancer cells.
Zhao Q; Huo XC; Sun FD; Dong RQ
Mol Med Rep; 2015 Oct; 12(4):4843-50. PubMed ID: 26165362
[TBL] [Abstract][Full Text] [Related]
7. Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134.
Hashim YM; Spitzer D; Vangveravong S; Hornick MC; Garg G; Hornick JR; Goedegebuure P; Mach RH; Hawkins WG
Mol Oncol; 2014 Jul; 8(5):956-67. PubMed ID: 24731702
[TBL] [Abstract][Full Text] [Related]
8. Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers.
Rajbhandari N; Lin WC; Wehde BL; Triplett AA; Wagner KU
Cell Rep; 2017 Feb; 18(9):2243-2255. PubMed ID: 28249168
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of seaweeds.
Gutiérrez-Rodríguez AG; Juárez-Portilla C; Olivares-Bañuelos T; Zepeda RC
Drug Discov Today; 2018 Feb; 23(2):434-447. PubMed ID: 29107095
[TBL] [Abstract][Full Text] [Related]
10. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
11. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
12. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells.
Pathania D; Kuang Y; Sechi M; Neamati N
Br J Pharmacol; 2015 Jan; 172(1):50-63. PubMed ID: 25047070
[TBL] [Abstract][Full Text] [Related]
14. The Role of Natural Polyphenols in the Prevention and Treatment of Cervical Cancer-An Overview.
Moga MA; Dimienescu OG; Arvatescu CA; Mironescu A; Dracea L; Ples L
Molecules; 2016 Aug; 21(8):. PubMed ID: 27548122
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer.
Chatterjee M; Ben-Josef E; Thomas DG; Morgan MA; Zalupski MM; Khan G; Andrew Robinson C; Griffith KA; Chen CS; Ludwig T; Bekaii-Saab T; Chakravarti A; Williams TM
Sci Rep; 2015 Jun; 5():10867. PubMed ID: 26065715
[TBL] [Abstract][Full Text] [Related]
16. Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor.
Zhang Z; Guo Y; Chen M; Chen F; Liu B; Shen C
Inflammopharmacology; 2021 Oct; 29(5):1587-1601. PubMed ID: 34322786
[TBL] [Abstract][Full Text] [Related]
17. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis.
Mouria M; Gukovskaya AS; Jung Y; Buechler P; Hines OJ; Reber HA; Pandol SJ
Int J Cancer; 2002 Apr; 98(5):761-9. PubMed ID: 11920648
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer.
Jiang W; Zhao S; Xu L; Lu Y; Lu Z; Chen C; Ni J; Wan R; Yang L
Biomed Pharmacother; 2015 Jul; 73():40-7. PubMed ID: 26211581
[TBL] [Abstract][Full Text] [Related]
19. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
20. Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAPK signaling pathways.
Xue N; Jin J; Liu D; Yan R; Zhang S; Yu X; Chen X
Curr Cancer Drug Targets; 2014; 14(7):671-83. PubMed ID: 25219422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
